Investigational Site Number : 0320013

Lobos, Buenos Aires 7240

0 studies enrolling now · 2 studies all time

What they study most

Asthma, Chronic Obstructive Pulmonary Disease

Studies at this site

• Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma — Running, not enrolling
• Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 Inflammation — Completed